Is Carfilzomib included in medical insurance? How to reimburse?
Carfilzomib is a drug used to treat multiple myeloma (Multiple Myeloma) and other related blood cancers. It belongs to a class of drugs called proteasome inhibitors. The mechanism of action of this type of drug is to target the proteasome in cancer cells and prevent its normal function, thereby leading to the death of cancer cells.
Carfilzomib has been launched in China and is included in medical insurance. Patients can purchase it domestically at a price of around 8,000 to 9,000 yuan. Please consult the local hospital pharmacy for specific prices. In foreign countries, the original drug of carfilzomib is mainly available, and the cheaper version is the European version of the original drug, which costs around 5,000. And the medicinal ingredients and efficacy are the same as those of domestic original medicines.

Proteasome inhibition: Carfilzomib inhibits the protein degradation process by interfering with the function of the proteasome. The proteasome is a subcellular organelle within cells that is responsible for breaking down aged, abnormal or harmful proteins into their component parts and maintaining the balance of intracellular proteins. The inhibitory effects of carfilzomib cause abnormal proteins to accumulate within cancer cells, ultimately leading to the death of these cancer cells.
Carfilzomib can also induce apoptosis, a process of programmed cell death, in cancer cells. Apoptosis is an important defense mechanism that helps eliminate problematic cells, including cancer cells, to maintain normal cellular ecological balance.
Carfilzomib is often used in clinical practice in combination with other drugs as first-line treatment or as part of relapse treatment. It offers patients with multiple myeloma a powerful treatment option that can help extend survival, reduce disease symptoms, and improve quality of life. However, the use of carfilzomib must be done under the supervision of a trained medical professional as it may cause some adverse reactions and side effects.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)